Back to Agenda
Session 1: Local and Multi-regional Clinical Development (Strategy and Implementation)
Session Chair(s)
Wei Zhang
VP, Regional Head of Biometrics and Data Management, Asia/MENA
Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd., China
Speaker(s)
Ning Li, MD, PhD
Sanofi, China
Vice President, Head of Asia Regulatory and Medical Policy
Sample Size Considerations in Multi-regional Clinical Trials
Luyan Dai, PhD
Boehringer Ingelheim, Shanghai, China
Associate Director, Biostatistics
Scientific Rigor in the Design of Simultaneous Global Drug Development - From Regulatory and Practical Perspectives
Gang CHEN, PhD
Johnson & Johnson, China
Have an account?